Biotech Consulting & Product Development

Moving science from bench to where patients need it.

Remelin partners with biotech and cosmetic companies developing modern beauty and longevity products. We support every stage of research and development and turn promising discoveries into products that clear regulatory review, manufacturing, and launch.
The Remelin founding team
Start a conversation → See how we work
01
Discovery & feasibility
02
Preclinical development
03
Regulatory & clinical strategy
04
Manufacturing & CMC
05
Commercial launch

Remelin Principal Expertise:

6,000+
Projects completed since 2003
900+
Satisfied biotech and pharma clients
22
Countries with clinical and lab projects
35+
Years of leadership in science and business
What we do

Providing strategic consulting to help clients design, develop, and launch products with meaningful value.

Remelin partners with biotech and cosmetic companies developing modern beauty and longevity products. We support every stage of research and development and turn promising discoveries into products that clear regulatory review, manufacturing, and launch.

Cell culture work in a biosafety cabinet
01

Discovery Strategy

Target validation, competitive landscaping, and go/no-go frameworks that keep early research focused on the programs worth funding.

Lab team processing in vivo samples
02

Preclinical Development

Study design, CRO selection, and data packages built to withstand regulatory scrutiny before you ever file.

Preclinical specimen handling
03

Regulatory & Clinical Strategy

IND/CTA preparation, agency engagement, and trial design that anticipates review questions instead of reacting to them.

Laboratory glassware and instrumentation
04

Manufacturing & CMC

Process development and tech transfer support that scales from bench to GMP without losing product quality.

Remelin icon mark
05

Commercialization

Market access, pricing strategy, and launch planning grounded in payer and provider realities, not projections alone.

Reviewing documents at a desk
06

Fundraising Support

Data room preparation and scientific due diligence support for teams raising from investors who will ask hard questions.

How we work

One accountable team: yours and ours.

Our core expertise is complimented by knowledge of our trusted partners across R&D in major therapeutic areas, AI in health care and beyond, and in global manufacturing and distribution.

We work in close collaboration with your internal team, building a partnership and collaboration first.

Phase 01

Assess

We spend two to three weeks embedded with your team, reviewing existing data, interviewing your scientific and operational leads, and mapping the gaps between where the program stands and what the next milestone requires.

Phase 02

Build

We design the development plan, regulatory pathway, and resourcing model together with your team, stress-testing assumptions against precedent programs and current agency guidance before anything is finalized.

Phase 03

Execute

Our consultants stay engaged through execution — running study oversight, vendor management, and milestone tracking — so strategy doesn't stall the moment it meets the lab or the clinic.

Leadership

Led by scientists who've built this before.

Remelin is guided by leadership with decades of hands-on experience across research, translational medicine, and company building.

Dr. Olga Potapova at the microscope

Dr. Olga Potapova

Founder & CEO, Remelin

Dr. Potapova holds advanced degrees in physics and biochemistry, and completed postdoctoral research in cancer biology and molecular genetics. Her early career included oncology drug development work at Pfizer and SUGEN, contributing to targeted therapy programs, and she has served as a Principal Investigator for The Cancer Genome Atlas since 2010. Before founding Remelin, she built and led a global translational research and biospecimen organization, working with biopharma partners across oncology, diagnostics, and precision medicine. She brings this same bench-to-industry experience to guiding biotech and cosmetic companies through research, development, and product launch.

Tell us where your program stands. We'll tell you what the next milestone requires.

info@remelin.com →